share_log

ProPhase Labs Analyst Ratings

Benzinga ·  Aug 14, 2023 18:43
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/14/2023 127.64% HC Wainwright & Co. → $14 Reiterates Buy → Buy
06/02/2023 127.64% HC Wainwright & Co. → $14 Reiterates Buy → Buy
05/12/2023 127.64% HC Wainwright & Co. $15 → $14 Maintains Buy
03/08/2023 143.9% HC Wainwright & Co. → $15 Reiterates → Buy
02/23/2023 143.9% HC Wainwright & Co. → $15 Reiterates → Buy
02/16/2023 143.9% HC Wainwright & Co. → $15 Reiterates → Buy
02/07/2023 143.9% HC Wainwright & Co. → $15 Reiterates → Buy
11/11/2022 143.9% HC Wainwright & Co. $14 → $15 Maintains Buy
05/17/2022 127.64% HC Wainwright & Co. $16 → $14 Maintains Buy
03/31/2022 160.16% HC Wainwright & Co. $15 → $16 Maintains Buy
01/14/2022 143.9% HC Wainwright & Co. $12 → $15 Maintains Buy
12/20/2021 95.12% HC Wainwright & Co. → $12 Initiates Coverage On → Buy
10/13/2021 Dawson James Downgrades Buy → Neutral

What is the target price for ProPhase Labs (PRPH)?

The latest price target for ProPhase Labs (NASDAQ: PRPH) was reported by HC Wainwright & Co. on August 14, 2023. The analyst firm set a price target for $14.00 expecting PRPH to rise to within 12 months (a possible 127.64% upside). 8 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for ProPhase Labs (PRPH)?

The latest analyst rating for ProPhase Labs (NASDAQ: PRPH) was provided by HC Wainwright & Co., and ProPhase Labs reiterated their buy rating.

When is the next analyst rating going to be posted or updated for ProPhase Labs (PRPH)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ProPhase Labs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ProPhase Labs was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.

Is the Analyst Rating ProPhase Labs (PRPH) correct?

While ratings are subjective and will change, the latest ProPhase Labs (PRPH) rating was a reiterated with a price target of $0.00 to $14.00. The current price ProPhase Labs (PRPH) is trading at is $6.15, which is within the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment